Home » Healthcare » Autoimmune Diseases Treatment Market

Autoimmune Diseases Treatment Market By Product Type (B Cell Inhibitors, T Cell Inhibitors, Tumor Necrosis Factor ,Inhibitors, Interleukin Inhibitors ,Immunosuppressants, Beta Interferons, Insulin, Others) By Application (Graves Disease ,Rheumatoid Arthritis , Hashimotos Thyroiditis, Vitiligo, Type 1 Diabetes, Pernicious Anemia ,Others) Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $4999

Published: | Report ID: 2712 | Report Format : PDF

Key Highlights of the Report

How are the major segments performing in the Autoimmune Diseases Treatment market?

  • B Cell Inhibitors accounted for the largest market share in 2022 due to the growing number of new product approvals.
  • Rheumatoid Arthritis was anticipated to hold a major share of the global Autoimmune Diseases Treatment market in 2022 due to the growing prevalence of the disease and the rising number of geriatric patients.
  • Hospitals & Clinics accounted for the largest market share in 2022 due to the rising number of hospitals and patient’s preference for treatment in hospitals with advanced instruments.
  • Multiple Sclerosis was anticipated to hold a major share of the global Autoimmune Diseases Treatment market in 2022 as the elderly population is more susceptible to the disease.
  • TNF Inhibitors accounted for the largest market share in 2022 as they help to stop inflammation.
  • Autoantibody Tests were anticipated to hold a major share of the global Autoimmune Diseases Treatment market in 2022. Autoantibody tests are carried out along with x-rays, imaging scans, and biopsies to diagnose an autoimmune condition.
  • Drugs accounted for the largest market share in 2022 due to growing R&D activities, investments, and new drug launches.
  • Diagnostic Equipment was anticipated to hold a major share of the global Autoimmune Diseases Treatment market in 2022 due to the growing demand for this equipment and the growing prevalence of diseases.

What is the Market Size of Autoimmune Diseases Treatment regarding value?

The global Autoimmune Diseases Treatment market is anticipated to grow at a substantial CAGR of 3.90% in the upcoming years. The global Autoimmune Diseases Treatment industry was estimated to be worth USD 159.6 billion in 2022 and was expected to be worth USD 208.61 billion by 2030.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Which Region dominated the Autoimmune Diseases Treatment market?

It was predicted that in 2022, the North American Region will have the highest proportion of the worldwide market for treatments for autoimmune diseases. North America is expected to remain the largest market for autoimmune therapies over the forecasted time frame. This is because autoimmune diseases are becoming more common in the region. The government is expected to enhance its funding for research and development into autoimmune diseases. Diagnosing, treating, and managing autoimmune diseases can benefit greatly from increased NIH funding.

Which are the key countries in the Autoimmune Diseases Treatment market?

The high standard of living in the United States and the large number of people suffering from autoimmune diseases have helped fuel the growth of this industry.

The German market would probably work better if healthcare reimbursement standards were modified and government entities were given greater funding for research and development. The government and pharmaceutical corporations are making increased investments in R&D to develop new drugs and cures, which should lead to the market increase in the next years

How is the economy impacting the global Autoimmune Diseases Treatment growth?

The COVID-19 epidemic negatively impacted market expansion. Infections and cardiovascular co-morbidities are more common in patients with autoimmune rheumatic disorders. The development of autoantibodies, autoimmune thyroid disorders, Kawasaki disease, Guillain-Barre syndrome, and immunological thrombocytopenic purpura are all signs that COVID-19 can trigger autoimmunity. Therefore, patients with such disorders were more vulnerable. The pandemic so had a negative impact on market expansion.

What is the competitive environment of the Autoimmune Diseases Treatment market?

Market participants are focusing on organic farming techniques, such as new product launches, regulatory approvals, and other developments. Pharmaceuticals targeting autoimmune diseases are expected to have strong growth potential due to rising demand in this market. In June 2022, Roivant Sciences and Pfizer unveiled Priovant Therapeutics, while in February 2022, Revolo Biotherapeutics gained authorisation from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) to begin two Phase II trials of their prospective autoimmune disease medication “1805.” The highest rates of morbidity and death are associated with autoimmune illnesses, and that is exactly what this firm aims to address.

Executive Summary

What are the key trends in the Autoimmune Diseases Treatment market?

  • Autoimmune disorders (AIDs) frequently co-occur, and 25% of patients with one AID are more likely to develop comorbid AIDs. GI, neuronal, ocular, cutaneous, musculoskeletal, cardiovascular, kidneys and lungs, hematopoietic, endocrine, and numerous systems are some groups that AIDs falls under.
  • Treatments becoming widely accessible, technological developments in screening procedures, and the popularity of pipeline drugs like baricitinib, certolizumab, secukinumab, and others are all anticipated to benefit the market’s growth. These additional elements are causing the market for treating autoimmune diseases to expand in value.

How is the Growing Prevalence of Autoimmune Disorders Affecting the Growth of the Autoimmune Diseases Treatment Market?

Multiple sclerosis affects around 2.8 million individuals worldwide and over 1 million people in the United States alone, according to the 2020 Atlas of Multiple Sclerosis. The European Union is concerned about the increasing incidence of autoimmune illnesses. The Multiple Sclerosis Trust estimates that by 2020, Europe will be home to a third of the world’s 2.5 million MS patients. Women are more likely to be diagnosed with MS than males. Rheumatoid arthritis affects two million individuals, whereas psoriasis, another prevalent inflammatory illness, affects two to three percent of the population. One of the key factors promoting increased usage rates is the expanding awareness of autoimmune diseases as a consequence of initiatives for research, support, education, and advocacy. The American Autoimmune Related Disease Association (AARDA) “is a non-profit organization whose mission is to eliminate autoimmune diseases, reduce their suffering, and address the societal and economic consequences of this epidemic.

Which are the key investments by the Autoimmune Diseases Treatment market players?

The major pharmaceutical companies are spending much money on developing new therapies for autoimmune diseases, which is helping to drive the market growth for these drugs worldwide. The Japanese firm focuses its R&D efforts on treatments for autoimmune disorders and is preparing to expand into harmonic T cell-based cancer treatments. A Phase II clinical trial has begun with one of the two medications currently in development. In 2018, the company restructured and moved its registration to Taiwan. In total, it has invested more than $33 million. It plans to go public in Taiwan in 2023, and it has raised $5 million toward a $12 million IPO.

Some major Autoimmune Diseases Treatment market players are Abbvie, Amgen Inc., Johnson & Johnson, Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche AG, AstraZeneca Plc, Bristol-Myers Squibb Co., Lupin Limited, GlaxoSmithKline Plc.

What are the Major Driving Factors for the Autoimmune Diseases Treatment Market?

The increasing incidence of autoimmune diseases is the primary force behind market growth. Market development over the forecast period is expected to be bolstered by rising public awareness of available treatment options. The government and pharmaceutical companies are investing more money into research and development (R&D) initiatives to develop new medicines and cures, which are expected to boost the industry during the next six years. The market for autoimmune disease treatment is expected to rise due to rising demand from developing countries and advances in healthcare technology.

What are the Major Risks for the Autoimmune Diseases Treatment Market?

However, among other things, the market will be constrained by a lack of skilled technicians and a growing lack of knowledge about the fundamental causes of various autoimmune diseases. This will make the market for treating autoimmune diseases more difficult to expand during the forecast period.

Which is the key application in the Autoimmune Diseases Treatment market?

During the forecast period, the multiple sclerosis segment will hold a major share of the global Autoimmune Diseases Treatment market. An immune-mediated disorder called multiple sclerosis (MS) involves the body’s immune system responding abnormally to the central nervous system (CNS). Similar to this, in March 2021, the United States Food and Drug Administration (FDA) approved the use of the drug Ponvory (ponesimod) by the Janssen Pharmaceutical Companies of Johnson & Johnson for the treatment of relapsing forms of multiple sclerosis (MS) in adults, such as relapsing-remitting, clinically isolated syndrome, and active secondary-progressive forms of MS. As a result, the studied segment is anticipated to have considerable expansion throughout the forecast period due to the growing pipeline of medications and new product launches as well as the high prevalence of MS.

How is the Autoimmune Diseases Treatment market performing in regions?

The markets in Asia and the Pacific are expected to follow North America’s in the next years. Over the forecast period, Asia Pacific is expected to develop significantly because of the region’s fast-improving healthcare infrastructure and rising patient awareness of the need for early diagnosis and treatment for autoimmune diseases. Increasing research and development, activity might promote optimal remedies in the market. Technical improvements in screening methods, the widespread availability of medicines, and the major presence of pipeline pharmaceuticals like baricitinib, certolizumab, secukinumab, and others are expected to affect the development of the industry significantly.

What is the regulatory landscape for the Autoimmune Diseases Treatment market?

Regulatory agencies like the Food and Drug Administration (FDA) in the United States and the European Medicines Agency (EMA) in Europe control medication approved for treating autoimmune illnesses. The FDA requires drug makers to submit data proving the efficacy and safety of their products as well as details on their pharmacology, production, and labeling.

What is the Market Size of Autoimmune Diseases Treatment regarding value?

The global Autoimmune Diseases Treatment market is anticipated to grow at a substantial CAGR of 3.90% in the upcoming years. The global Autoimmune Diseases Treatment industry was estimated to be worth USD 159.6 billion in 2022 and was expected to be worth USD 208.61 billion by 2030.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

What are the major players planning for the future of the Autoimmune Diseases Treatment market?

Several new technologies, including drinkable diagnostic tools and novel biomarkers, are expected to become more widely adopted during the projected time. To create effective therapeutic solutions for the end-users, the autoimmune disease therapeutics market start-up businesses are increasing their attention on routine innovation and engaging in mergers and acquisitions.

REPORT ATTRIBUTE DETAILS
Autoimmune Diseases Treatment Market by Value Yes
Autoimmune Diseases Treatment Market, Tornado Analysis Yes
Autoimmune Diseases Treatment Market, STAR Analysis Yes
Autoimmune Diseases Treatment Market, SRC Analysis Yes
Autoimmune Diseases Treatment Market Pricing Analysis Yes (On Demand)
Autoimmune Diseases Treatment Market Segment Analysis By Product Type (B Cell Inhibitors, T Cell Inhibitors, Tumor Necrosis Factor, Inhibitors, Interleukin Inhibitors, Immunosuppressants, Beta Interferons, Insulin, and Others)

By Application (Graves Disease, Rheumatoid Arthritis, Hashimotos Thyroiditis, Vitiligo, Type 1 Diabetes, Pernicious Anemia, and Others)

By Distribution Channel (Hospitals & Clinics,  Diagnostic Centers, Drug Stores, Pharmacies, and Others)

By Disease (Crohn’s Disease, Rheumatoid Arthritis, Inflammatory Bowel Disease, Multiple Sclerosis, Systemic Lupus Erythematosus, Psoriasis, and Ankylosing Spondylitis)

By Mechanism of Action (TNF Inhibitors, IL Blockers, COX Inhibitors, and Phosphodiesterase Type 4 Inhibitors)

By Diagnostic (Autoantibody Tests, Antinuclear Antibody Tests, Urinalysis, Comprehensive Metabolic Panel, and Erythrocyte Sedimentation Rate)

By Treatment (Drugs and Physical Therapy)

By Product (Diagnostic Equipment, Drugs, and Therapeutic & Monitoring Equipment)

Autoimmune Diseases Treatment Market, Regional Analysis North America (US and Canada)

Europe (Germany, UK, France, Italy, Spain, and Rest of Europe)

Asia Pacific (China, India, Japan, South Korea, South East Asia, and Rest of Asia Pacific)

Latin America (Brazil, Mexico, and Rest of Latin America)

Middle East and Africa (GCC Countries, South Africa, and the Rest of the Middle East and Africa)

Autoimmune Diseases Treatment Market Key Companies Abbvie, Amgen Inc., Johnson & Johnson, Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche AG, AstraZeneca Plc, Bristol-Myers Squibb Co., Lupin Limited, and GlaxoSmithKline Plc
Autoimmune Diseases Treatment Market Competitive Landscape Market Share Analysis

Competitive Benchmarking

Key Players Market Positioning

Geographical Presence Analysis

Major Strategies Adopted

Segmentation of Global Autoimmune Diseases Treatment Market-

Global Autoimmune Diseases Treatment Market – By Product Type

  • B Cell Inhibitors
  • T Cell Inhibitors
  • Tumor Necrosis Factor
  • Inhibitors
  • Interleukin Inhibitors
  • Immunosuppressants
  • Beta Interferons
  • Insulin
  • Others

Global Autoimmune Diseases Treatment Market – By Application

  • Graves Disease
  • Rheumatoid Arthritis
  • Hashimotos Thyroiditis
  • Vitiligo
  • Type 1 Diabetes
  • Pernicious Anemia
  • Others

Global Autoimmune Diseases Treatment Market – By Distribution Channel

  • Hospitals & Clinics
  • Diagnostic Centers
  • Drug Stores
  • Pharmacies
  • Others

Global Autoimmune Diseases Treatment Market – By Disease

  • Crohn’s Disease
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Multiple Sclerosis
  • Systemic Lupus Erythematosus
  • Psoriasis
  • Ankylosing Spondylitis

Global Autoimmune Diseases Treatment Market – By Mechanism of Action

  • TNF Inhibitors
  • IL Blockers
  • COX Inhibitors
  • Phosphodiesterase Type 4 Inhibitors

Global Autoimmune Diseases Treatment Market – By Diagnostic

  • Autoantibody Tests
  • Antinuclear Antibody Tests
  • Urinalysis
  • Comprehensive Metabolic Panel
  • Erythrocyte Sedimentation Rate

Global Autoimmune Diseases Treatment Market – By Treatment

  • Drugs
  • Physical Therapy

Global Autoimmune Diseases Treatment Market – By Product

  • Diagnostic Equipment
  • Drugs
  • Therapeutic & Monitoring Equipment

Global Autoimmune Diseases Treatment Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Autoimmune Diseases Treatment Market
2.2. Global Autoimmune Diseases Treatment Market, By Product Type
2.3. Global Autoimmune Diseases Treatment Market, By Application
2.4. Global Autoimmune Diseases Treatment Market, By Distribution Channel
2.5. Global Autoimmune Diseases Treatment Market, By Disease
2.6. Global Autoimmune Diseases Treatment Market, By Mechanism of Action
2.7. Global Autoimmune Diseases Treatment Market, By Diagnostic
2.8. Global Autoimmune Diseases Treatment Market, By Treatment
2.9. Global Autoimmune Diseases Treatment Market, By Product
2.10. Global Autoimmune Diseases Treatment Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Autoimmune Diseases Treatment Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.2.4. Major Industry Challenges
3.2.4.1. Challenge 1
3.2.4.2. Challenge 2
3.3. Growth and Development and Extracellular Vesicles Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product Type
3.5.2. Application
3.5.3. Distribution Channel
3.5.4. Disease
3.5.5. Product
3.5.6. Diagnostic
3.5.7. Treatment
3.5.8. Product
3.5.9. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Product Type Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Latin America
6.1.5. Middle East and Africa
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.2.2. Europe
6.2.3. Asia Pacific
6.2.4. Latin America
6.2.5. Middle East and Africa
6.3. COVID-19 Impact Analysis
6.3.1. North America
6.3.2. Europe
6.3.3. Asia Pacific
6.3.4. Latin America
6.3.5. Middle East and Africa

7. Global Autoimmune Diseases Treatment Market, By Product Type
7.1. Global Autoimmune Diseases Treatment Market Overview, by Product Type
7.1.1. Global Autoimmune Diseases Treatment Market Revenue Share, By Product Type, 2022 Vs 2030 (in %)
7.2. B Cell Inhibitors
7.2.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
7.3. T Cell Inhibitors
7.3.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
7.4. Tumor Necrosis Factor
7.4.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
7.5. Interleukin Inhibitors
7.5.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
7.6. Immunosuppressants
7.6.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
7.7. Beta Interferons
7.7.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
7.8. Insulin
7.8.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
7.9. Others
7.9.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)

8. Global Autoimmune Diseases Treatment Market, By Application
8.1. Global Autoimmune Diseases Treatment Market Overview, by Application
8.1.1. Global Autoimmune Diseases Treatment Market, By Application, 2022 vs 2030 (in %)
8.2. Graves Disease
8.2.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
8.3. Rheumatoid Arthritis
8.3.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
8.4. Hashimotos Thyroidtis
8.4.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
8.5. Vitiligo
8.5.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
8.6. Type 1 Diabetes
8.6.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
8.7. Pernicious Anemia
8.7.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
8.8. Others
8.8.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)

9. Global Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2030 (US$ Bn)
9.1. Global Autoimmune Diseases Treatment Market Overview, by Distribution Channel
9.1.1. Global Autoimmune Diseases Treatment Market, By Distribution Channel, 2022 vs 2030 (in%)
9.2. Hospitals & Clinics
9.2.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
9.3. Diagnostic Centers
9.3.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
9.4. Drug Stores
9.4.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
9.5. Pharmacies
9.5.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
9.6. Others
9.6.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)

10. Global Autoimmune Diseases Treatment Market, by Disease, 2017-2030 (US$ Bn)
10.1. Global Autoimmune Diseases Treatment Market Overview, by Disease
10.1.1. Global Autoimmune Diseases Treatment Market, By Disease, 2022 vs 2030 (in%)
10.2. Crohn’s Disease
10.2.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
10.3. Rheumatoid Arthritis
10.3.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
10.4. Inflammatory Bowel Disease
10.4.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
10.5. Multiple Sclerosis
10.5.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
10.6. Systemic Lupus Erythematosus
10.6.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
10.7. Psoriasis
10.7.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
10.8. Ankylosing Spondylitis
10.8.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)

11. Global Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2030 (US$ Bn)
11.1. Global Autoimmune Diseases Treatment Market Overview, by Mechanism of Action
11.1.1. Global Autoimmune Diseases Treatment Market, By Mechanism of Action, 2022 vs 2030 (in%)
11.2. TNF Inhibitors
11.2.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
11.3. IL Blockers
11.3.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
11.4. COX Inhibitors
11.4.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
11.5. Phosphodiesterase Type 4 Inhibitors
11.5.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)

12. Global Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2030 (US$ Bn)
12.1. Global Autoimmune Diseases Treatment Market Overview, by Diagnostic
12.1.1. Global Autoimmune Diseases Treatment Market, By Diagnostic, 2022 vs 2030 (in%)
12.2. Autoantibody Tests
12.2.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
12.3. Antinuclear Antibody Tests
12.3.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
12.4. Urinalysis
12.4.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
12.5. Comprehensive Metabolic Panel
12.5.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
12.6. Erythrocyte Sedimentation Rate
12.6.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)

13. Global Autoimmune Diseases Treatment Market, by Treatment, 2017-2030 (US$ Bn)
13.1. Global Autoimmune Diseases Treatment Market Overview, by Treatment
13.1.1. Global Autoimmune Diseases Treatment Market, By Treatment, 2022 vs 2030 (in%)
13.2. Drugs
13.2.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
13.3. Physical Therapy
13.3.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
14. Global Autoimmune Diseases Treatment Market, by Product, 2017-2030 (US$ Bn)
14.1. Global Autoimmune Diseases Treatment Market Overview, by Product
14.1.1. Global Autoimmune Diseases Treatment Market, By Product, 2022 vs 2030 (in%)
14.2. Diagnostic Equipment
14.2.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
14.3. Drugs
14.3.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)
14.4. Therapeutic & Monitoring Equipment
14.4.1. Global Autoimmune Diseases Treatment Market, By Region, 2017-2030 (US$ Bn)

15. Global Autoimmune Diseases Treatment Market, By Region
15.1. Global Autoimmune Diseases Treatment Market Overview, by Region
15.1.1. Global Autoimmune Diseases Treatment Market, By Region, 2022 vs 2030 (in%)
15.2. Product Type
15.2.1. Global Autoimmune Diseases Treatment Market, By Product Type, 2017-2030 (US$ Bn)
15.3. Application
15.3.1. Global Autoimmune Diseases Treatment Market, By Application, 2017-2030 (US$ Bn)
15.4. Distribution Channel
15.4.1. Global Autoimmune Diseases Treatment Market, By Distribution Channel, 2017-2030 (US$ Bn)
15.5. Disease
15.5.1. Global Autoimmune Diseases Treatment Market, By Disease, 2017-2030 (US$ Bn)
15.6. Mechanism of Action
15.6.1. Global Autoimmune Diseases Treatment Market, By Mechanism of Action, 2017-2030 (US$ Bn)
15.7. Diagnostic
15.7.1. Global Autoimmune Diseases Treatment Market, By Diagnostic, 2017-2030 (US$ Bn)
15.8. Treatment
15.8.1. Global Autoimmune Diseases Treatment Market, By Treatment, 2017-2030 (US$ Bn)
15.9. Product
15.9.1. Global Autoimmune Diseases Treatment Market, By Product, 2017-2030 (US$ Bn)

16. North America Autoimmune Diseases Treatment Market Analysis
16.1. North America Autoimmune Diseases Treatment Market, by Product Type, 2017-2030(US$ Bn)
16.1.1. Overview
16.1.2. SRC Analysis
16.2. North America Autoimmune Diseases Treatment Market, by Application, 2017-2030(US$ Bn)
16.2.1. Overview
16.2.2. SRC Analysis
16.3. North America Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
16.3.1. Overview
16.3.2. SRC Analysis
16.4. North America Autoimmune Diseases Treatment Market, by Disease, 2017-2030(US$ Bn)
16.4.1. Overview
16.4.2. SRC Analysis
16.5. North America Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2030(US$ Bn)
16.5.1. Overview
16.5.2. SRC Analysis
16.6. North America Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2030(US$ Bn)
16.6.1. Overview
16.6.2. SRC Analysis
16.7. North America Autoimmune Diseases Treatment Market, by Treatment, 2017-2030(US$ Bn)
16.7.1. Overview
16.7.2. SRC Analysis
16.8. North America Autoimmune Diseases Treatment Market, by Product, 2017-2030(US$ Bn)
16.8.1. Overview
16.8.2. SRC Analysis
16.9. North America Autoimmune Diseases Treatment Market, by Country, 2017-2030 (US$ Bn)
16.9.1. North America Autoimmune Diseases Treatment Market, by Country, 2022 Vs 2030 (in%)
16.9.2. U.S.
16.9.2.1. U.S. Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.9.2.2. U.S. Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
16.9.2.3. U.S. Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
16.9.2.4. U.S. Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
16.9.2.5. U.S. Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
16.9.2.6. U.S. Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
16.9.2.7. U.S. Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
16.9.2.8. U.S. Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
16.9.2.9. U.S. Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
16.9.3. Canada
16.9.3.1. Canada Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.9.3.2. Canada Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
16.9.3.3. Canada Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
16.9.3.4. Canada Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
16.9.3.5. Canada Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
16.9.3.6. Canada Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
16.9.3.7. Canada Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
16.9.3.8. Canada Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
16.9.3.9. Canada Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
16.9.3.10.
16.9.4. Mexico
16.9.4.1. Mexico Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
16.9.4.2. Mexico Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
16.9.4.3. Mexico Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
16.9.4.4. Mexico Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
16.9.4.5. Mexico Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
16.9.4.6. Mexico Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
16.9.4.7. Mexico Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
16.9.4.8. Mexico Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
16.9.4.9. Mexico Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)

17. Europe Autoimmune Diseases Treatment Market Analysis
17.1. Europe Autoimmune Diseases Treatment Market, by Product Type, 2017-2030(US$ Bn)
17.1.1. Overview
17.1.2. SRC Analysis
17.2. Europe Autoimmune Diseases Treatment Market, by Application, 2017-2030(US$ Bn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. Europe Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. Europe Autoimmune Diseases Treatment Market, by Disease, 2017-2030(US$ Bn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. Europe Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2030(US$ Bn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. Europe Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2030(US$ Bn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. Europe Autoimmune Diseases Treatment Market, by Treatment, 2017-2030(US$ Bn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. Europe Autoimmune Diseases Treatment Market, by Product, 2017-2030(US$ Bn)
17.8.1. Overview
17.8.2. SRC Analysis
17.9. Europe Autoimmune Diseases Treatment Market, by Country, 2017-2030 (US$ Bn)
17.9.1. Europe Autoimmune Diseases Treatment Market, by Country, 2022 Vs 2030 (in%)
17.9.2. Germany
17.9.2.1. Germany Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.2.2. Germany Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
17.9.2.3. Germany Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
17.9.2.4. Germany Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
17.9.2.5. Germany Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
17.9.2.6. Germany Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
17.9.2.7. Germany Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
17.9.2.8. Germany Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
17.9.2.9. Germany Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
17.9.3. France
17.9.3.1. France Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.3.2. France Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
17.9.3.3. France Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
17.9.3.4. France Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
17.9.3.5. France Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
17.9.3.6. France Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
17.9.3.7. France Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
17.9.3.8. France Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
17.9.3.9. France Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
17.9.4. UK
17.9.4.1. UK Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.4.2. UK Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
17.9.4.3. UK Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
17.9.4.4. UK Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
17.9.4.5. UK Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
17.9.4.6. UK Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
17.9.4.7. UK Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
17.9.4.8. UK Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
17.9.4.9. UK Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
17.9.5. Italy
17.9.5.1. Italy Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.5.2. Italy Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
17.9.5.3. Italy Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
17.9.5.4. Italy Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
17.9.5.5. Italy Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
17.9.5.6. Italy Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
17.9.5.7. Italy Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
17.9.5.8. Italy Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
17.9.5.9. Italy Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
17.9.6. Spain
17.9.6.1. Spain Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.6.2. Spain Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
17.9.6.3. Spain Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
17.9.6.4. Spain Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
17.9.6.5. Spain Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
17.9.6.6. Spain Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
17.9.6.7. Spain Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
17.9.6.8. Spain Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
17.9.6.9. Spain Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
17.9.7. Rest of Europe
17.9.7.1. Rest of Europe Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
17.9.7.2. Rest of Europe Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
17.9.7.3. Rest of Europe Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
17.9.7.4. Rest of Europe Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
17.9.7.5. Rest of Europe Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
17.9.7.6. Rest of Europe Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
17.9.7.7. Rest of Europe Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
17.9.7.8. Rest of Europe Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
17.9.7.9. Rest of Europe Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)

18. Asia Pacific Autoimmune Diseases Treatment Market Analysis
18.1. Asia Pacific Autoimmune Diseases Treatment Market, by Product Type, 2017-2030(US$ Bn)
18.1.1. Overview
18.1.2. SRC Analysis
18.2. Asia Pacific Autoimmune Diseases Treatment Market, by Application, 2017-2030(US$ Bn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Asia Pacific Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Asia Pacific Autoimmune Diseases Treatment Market, by Disease, 2017-2030(US$ Bn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Asia Pacific Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2030(US$ Bn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Asia Pacific Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2030(US$ Bn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Asia Pacific Autoimmune Diseases Treatment Market, by Treatment, 2017-2030(US$ Bn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Asia Pacific Autoimmune Diseases Treatment Market, by Product, 2017-2030(US$ Bn)
18.8.1. Overview
18.8.2. SRC Analysis
18.9. Asia Pacific Autoimmune Diseases Treatment Market, by Country, 2017-2030 (US$ Bn)
18.9.1. Asia Pacific Autoimmune Diseases Treatment Market, by Country, 2022 Vs 2030 (in%)
18.9.2. China
18.9.2.1. China Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.2.2. China Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
18.9.2.3. China Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
18.9.2.4. China Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
18.9.2.5. China Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
18.9.2.6. China Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
18.9.2.7. China Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
18.9.2.8. China Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
18.9.2.9. China Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
18.9.3. Japan
18.9.3.1. Japan Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.3.2. Japan Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
18.9.3.3. Japan Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
18.9.3.4. Japan Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
18.9.3.5. Japan Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
18.9.3.6. Japan Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
18.9.3.7. Japan Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
18.9.3.8. Japan Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
18.9.3.9. Japan Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
18.9.4. India
18.9.4.1. India Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.4.2. India Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
18.9.4.3. India Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
18.9.4.4. India Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
18.9.4.5. India Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
18.9.4.6. India Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
18.9.4.7. India Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
18.9.4.8. India Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
18.9.4.9. India Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
18.9.5. South Korea
18.9.5.1. South Korea Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.5.2. South Korea Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
18.9.5.3. South Korea Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
18.9.5.4. South Korea Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
18.9.5.5. South Korea Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
18.9.5.6. South Korea Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
18.9.5.7. South Korea Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
18.9.5.8. South Korea Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
18.9.5.9. South Korea Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
18.9.6. South-East Asia
18.9.6.1. South-East Asia Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.6.2. South-East Asia Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
18.9.6.3. South-East Asia Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
18.9.6.4. South Korea Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
18.9.6.5. South Korea Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
18.9.6.6. South-East Asia Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
18.9.6.7. South Korea Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
18.9.6.8. South Korea Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
18.9.6.9. South Korea Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
18.9.7. Rest of Asia Pacific
18.9.7.1. Rest of Asia Pacific Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
18.9.7.2. Rest of Asia Pacific Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
18.9.7.3. Rest of Asia Pacific Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
18.9.7.4. Rest of Asia Pacific Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
18.9.7.5. Rest of Asia Pacific Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
18.9.7.6. Rest of Asia Pacific Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
18.9.7.7. Rest of Asia Pacific Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
18.9.7.8. Rest of Asia Pacific Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
18.9.7.9. Rest of Asia Pacific Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)

19. Latin America Autoimmune Diseases Treatment Market Analysis
19.1. Latin America Autoimmune Diseases Treatment Market, by Product Type, 2017-2030(US$ Bn)
19.1.1. Overview
19.1.2. SRC Analysis
19.2. Latin America Autoimmune Diseases Treatment Market, by Application, 2017-2030(US$ Bn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Latin America Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Latin America Autoimmune Diseases Treatment Market, by Disease, 2017-2030(US$ Bn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Latin America Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2030(US$ Bn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Latin America Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2030(US$ Bn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Latin America Autoimmune Diseases Treatment Market, by Treatment, 2017-2030(US$ Bn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Latin America Autoimmune Diseases Treatment Market, by Product, 2017-2030(US$ Bn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. Latin America Autoimmune Diseases Treatment Market, by Country, 2017-2030 (US$ Bn)
19.9.1. Latin America Autoimmune Diseases Treatment Market, by Country, 2022 Vs 2030 (in%)
19.9.2. Brazil
19.9.2.1. Brazil Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
19.9.2.2. Brazil Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
19.9.2.3. Brazil Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
19.9.2.4. Brazil Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
19.9.2.5. Brazil Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
19.9.2.6. Brazil Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
19.9.2.7. Brazil Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
19.9.2.8. Brazil Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
19.9.2.9. Brazil Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
19.9.3. Argentina
19.9.3.1. Argentina Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
19.9.3.2. Argentina Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
19.9.3.3. Argentina Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
19.9.3.4. Argentina Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
19.9.3.5. Argentina Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
19.9.3.6. Argentina Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
19.9.3.7. Argentina Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
19.9.3.8. Argentina Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
19.9.3.9. Argentina Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
19.9.4. Rest of Latin America
19.9.4.1. Rest of Latin America Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
19.9.4.2. Rest of Latin America Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
19.9.4.3. Rest of Latin America Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
19.9.4.4. Rest of Latin America Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
19.9.4.5. Rest of Latin America Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
19.9.4.6. Rest of Latin America Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
19.9.4.7. Rest of Latin America Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
19.9.4.8. Rest of Latin America Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
19.9.4.9. Rest of Latin America Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)

20. Middle East and Africa Autoimmune Diseases Treatment Market Analysis
20.1. Middle East and Africa Autoimmune Diseases Treatment Market, by Product Type, 2017-2030(US$ Bn)
20.1.1. Overview
20.1.2. SRC Analysis
20.2. Middle East and Africa Autoimmune Diseases Treatment Market, by Application, 2017-2030(US$ Bn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Middle East and Africa Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2030(US$ Bn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Middle East and Africa Autoimmune Diseases Treatment Market, by Disease, 2017-2030(US$ Bn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Middle East and Africa Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2030(US$ Bn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Middle East and Africa Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2030(US$ Bn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Middle East and Africa Autoimmune Diseases Treatment Market, by Treatment, 2017-2030(US$ Bn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Middle East and Africa Autoimmune Diseases Treatment Market, by Product, 2017-2030(US$ Bn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Middle East and Africa Autoimmune Diseases Treatment Market, by Country, 2017-2030 (US$ Bn)
20.9.1. Middle East and Africa Autoimmune Diseases Treatment Market, by Country, 2022 Vs 2030 (in%)
20.9.2. GCC Countries
20.9.2.1. GCC Countries Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
20.9.2.2. GCC Countries Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
20.9.2.3. GCC Countries Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
20.9.2.4. GCC Countries Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
20.9.2.5. GCC Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
20.9.2.6. GCC Countries Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
20.9.2.7. GCC Countries Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
20.9.2.8. GCC Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
20.9.2.9. GCC Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
20.9.3. South Africa
20.9.3.1. South Africa Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
20.9.3.2. South Africa Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
20.9.3.3. South Africa Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
20.9.3.4. South Africa Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
20.9.3.5. South Africa Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
20.9.3.6. South Africa Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
20.9.3.7. South Africa Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
20.9.3.8. South Africa Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
20.9.3.9. South Africa Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)
20.9.4. Rest of Middle East and Africa
20.9.4.1. Rest of Middle East and Africa Autoimmune Diseases Treatment Market Estimates and Forecast, 2017-2030 (US$ Bn)
20.9.4.2. Rest of Middle East and Africa Autoimmune Diseases Treatment, By Product Type, 2017-2030 (US$ Bn)
20.9.4.3. Rest of Middle East and Africa Autoimmune Diseases Treatment, By Application, 2017-2030 (US$ Bn)
20.9.4.4. Rest of Middle East and Africa Autoimmune Diseases Treatment, By Distribution Channel, 2017-2030 (US$ Bn)
20.9.4.5. Rest of Middle East and Africa Autoimmune Diseases Treatment, By Disease, 2017-2030 (US$ Bn)
20.9.4.6. Rest of Middle East and Africa Autoimmune Diseases Treatment, By Mechanism of Action, 2017-2030 (US$ Bn)
20.9.4.7. Rest of Middle East and Africa Autoimmune Diseases Treatment, By Diagnostic, 2017-2030 (US$ Bn)
20.9.4.8. Rest of Middle East and Africa Autoimmune Diseases Treatment, By Treatment, 2017-2030 (US$ Bn)
20.9.4.9. Rest of Middle East and Africa Autoimmune Diseases Treatment, By Product, 2017-2030 (US$ Bn)

21. Company Profiles
21.1. Abbvie
21.1.1. Company Overview
21.1.2. Diagnostic/Services Portfolio
21.1.3. Geographical Presence
21.1.4. Financial Summary
21.1.4.1. Market Revenue and Net Profit (2019-2022)
21.1.4.2. Business Segment Revenue Analysis
21.1.4.3. Geographical Revenue Analysis
21.2. Amgen Inc.
21.3. Johnson & Johnson
21.4. Eli Lilly and Company
21.5. Pfizer Inc.
21.6. F. Hoffmann-La Roche AG
21.7. Astrazeneca Plc
21.8. Bristol-Myers Squibb Co.
21.9. Lupin Limited
21.10. GlaxoSmithKline Plc

 

List of Figures
FIG. 1 Global Autoimmune Diseases Treatment Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Autoimmune Diseases Treatment Market Segment
FIG. 4 Global Autoimmune Diseases Treatment Market, by Product Type, 2022 (US$ Bn)
FIG. 5 Global Autoimmune Diseases Treatment Market, by Application, 2022 (US$ Bn)
FIG. 6 Global Autoimmune Diseases Treatment Market, by Distribution Channel, 2022 (US$ Bn)
FIG. 7 Global Autoimmune Diseases Treatment Market, by Disease, 2022 (US$ Bn)
FIG. 8 Global Autoimmune Diseases Treatment Market, by Mechanism of Action, 2022 (US$ Bn)
FIG. 9 Global Autoimmune Diseases Treatment Market, by Diagnostic, 2022 (US$ Bn)
FIG. 10 Global Autoimmune Diseases Treatment Market, by Treatment, 2022 (US$ Bn)
FIG. 11 Global Autoimmune Diseases Treatment Market, by Product, 2022 (US$ Bn)
FIG. 12 Global Autoimmune Diseases Treatment Market, by Geography, 2022 (US$ Bn)
FIG. 13 Attractive Investment Proposition, by Product Type, 2022
FIG. 14 Attractive Investment Proposition, by Application, 2022
FIG. 15 Attractive Investment Proposition, by Distribution Channel, 2022
FIG. 16 Attractive Investment Proposition, by Disease, 2022
FIG. 17 Attractive Investment Proposition, by Mechanism of Action, 2022
FIG. 18 Attractive Investment Proposition, by Diagnostic, 2022
FIG. 19 Attractive Investment Proposition, by Treatment, 2022
FIG. 20 Attractive Investment Proposition, by Product, 2022
FIG. 21 Attractive Investment Proposition, by Geography, 2022
FIG. 22 Global Market Share Analysis of Key Autoimmune Diseases Treatment Market Manufacturers, 2022
FIG. 23 Global Market Positioning of Key Autoimmune Diseases Treatment Market Manufacturers, 2022
FIG. 24 Global Autoimmune Diseases Treatment Market Value Contribution, By Product Type, 2022 & 2030 (Value %)
FIG. 25 Global Autoimmune Diseases Treatment Market, by B Cell Inhibitors, Value, 2017-2030 (US$ Bn)
FIG. 26 Global Autoimmune Diseases Treatment Market, by T Cell Inhibitors, Value, 2017-2030 (US$ Bn)
FIG. 27 Global Autoimmune Diseases Treatment Market, by Tumor Necrosis Factor, Value, 2017-2030 (US$ Bn)
FIG. 28 Global Autoimmune Diseases Treatment Market, by Inhibitors, Value, 2017-2030 (US$ Bn)
FIG. 29 Global Autoimmune Diseases Treatment Market, by Interleukin Inhibitors, Value, 2017-2030 (US$ Bn)
FIG. 30 Global Autoimmune Diseases Treatment Market, by Immunosuppressants, Value, 2017-2030 (US$ Bn)
FIG. 31 Global Autoimmune Diseases Treatment Market, by Beta Interferons, Value, 2017-2030 (US$ Bn)
FIG. 32 Global Autoimmune Diseases Treatment Market, by Insulin, Value, 2017-2030 (US$ Bn)
FIG. 33 Global Autoimmune Diseases Treatment Market, by Others, Value, 2017-2030 (US$ Bn)
FIG. 34 Global Autoimmune Diseases Treatment Market Value Contribution, By Application, 2022 & 2030 (Value %)
FIG. 35 Global Autoimmune Diseases Treatment Market, by Graves Disease, Value, 2017-2030 (US$ Bn)
FIG. 36 Global Autoimmune Diseases Treatment Market, by Rheumatoid Arthritis, 2017-2030 (US$ Bn)
FIG. 37 Global Autoimmune Diseases Treatment Market, by Library Hashimotos Thyroidtis, 2017-2030 (US$ Bn)
FIG. 38 Global Autoimmune Diseases Treatment Market, by Hashimotos Thyroidtis, 2017-2030 (US$ Bn)
FIG. 39 Global Autoimmune Diseases Treatment Market, by Vitiligo, 2017-2030 (US$ Bn)
FIG. 40 Global Autoimmune Diseases Treatment Market, by Type 1 Diabetes, 2017-2030 (US$ Bn)
FIG. 41 Global Autoimmune Diseases Treatment Market, by Pernicious Anemia, 2017-2030 (US$ Bn)
FIG. 42 Global Autoimmune Diseases Treatment Market, by Others, 2017-2030 (US$ Bn)
FIG. 43 Global Autoimmune Diseases Treatment Market Value Contribution, By Distribution Channel, 2022 & 2030 (Value %)
FIG. 44 Global Autoimmune Diseases Treatment Market, by Hospitals & Clinics, Value, 2017-2030 (US$ Bn)
FIG. 45 Global Autoimmune Diseases Treatment Market, by Diagnostic Centers, 2017-2030 (US$ Bn)
FIG. 46 Global Autoimmune Diseases Treatment Market, by Drug Stores, 2017-2030 (US$ Bn)
FIG. 47 Global Autoimmune Diseases Treatment Market, by Pharmacies, 2017-2030 (US$ Bn)
FIG. 48 Global Autoimmune Diseases Treatment Market, by Others, 2017-2030 (US$ Bn)
FIG. 49 Global Autoimmune Diseases Treatment Market Value Contribution, By Disease, 2022 & 2030 (Value %)
FIG. 50 Global Autoimmune Diseases Treatment Market, by Crohn’s Disease, Value, 2017-2030 (US$ Bn)
FIG. 51 Global Autoimmune Diseases Treatment Market, by Rheumatoid Arthritis, 2017-2030 (US$ Bn)
FIG. 52 Global Autoimmune Diseases Treatment Market, by Inflammatory Bowel Disease, 2017-2030 (US$ Bn)
FIG. 53 Global Autoimmune Diseases Treatment Market, by Multiple Sclerosis, Value, 2017-2030 (US$ Bn)
FIG. 54 Global Autoimmune Diseases Treatment Market, by Systemic Lupus Erythematosus, Value, 2017-2030 (US$ Bn)
FIG. 55 Global Autoimmune Diseases Treatment Market, by Psoriasis, Value, 2017-2030 (US$ Bn)
FIG. 56 Global Autoimmune Diseases Treatment Market, by Ankylosing Spondylitis, Value, 2017-2030 (US$ Bn)
FIG. 57 Global Autoimmune Diseases Treatment Market Value Contribution, By Mechanism of Action, 2022 & 2030 (Value %)
FIG. 58 Global Autoimmune Diseases Treatment Market, by TNF Inhibitors, 2017-2030 (US$ Bn)
FIG. 59 Global Autoimmune Diseases Treatment Market, by IL Blockers, 2017-2030 (US$ Bn)
FIG. 60 Global Autoimmune Diseases Treatment Market, by COX Inhibitors, 2017-2030 (US$ Bn)
FIG. 61 Global Autoimmune Diseases Treatment Market, by Phosphodiesterase Type 4 Inhibitors, 2017-2030 (US$ Bn)
FIG. 62 Global Autoimmune Diseases Treatment Market Value Contribution, By Diagnostic, 2022 & 2030 (Value %)
FIG. 63 Global Autoimmune Diseases Treatment Market, by Autoantibody Tests, 2017-2030 (US$ Bn)
FIG. 64 Global Autoimmune Diseases Treatment Market, by Antinuclear Antibody Tests, 2017-2030 (US$ Bn)
FIG. 65 Global Autoimmune Diseases Treatment Market, by Urinalysis, 2017-2030 (US$ Bn)
FIG. 66 Global Autoimmune Diseases Treatment Market, by Comprehensive Metabolic Panel, 2017-2030 (US$ Bn)
FIG. 67 Global Autoimmune Diseases Treatment Market, by Erythrocyte Sedimentation Rate, 2017-2030 (US$ Bn)
FIG. 68 Global Autoimmune Diseases Treatment Market Value Contribution, By Treatment, 2022 & 2030 (Value %)
FIG. 69 Global Autoimmune Diseases Treatment Market, by Drugs, 2017-2030 (US$ Bn)
FIG. 70 Global Autoimmune Diseases Treatment Market, by Physical Therapy, 2017-2030 (US$ Bn)
FIG. 71 Global Autoimmune Diseases Treatment Market Value Contribution, By Product, 2022 & 2030 (Value %)
FIG. 72 Global Autoimmune Diseases Treatment Market, by Diagnostic Equipment, 2017-2030 (US$ Bn)
FIG. 73 Global Autoimmune Diseases Treatment Market, by Drugs, 2017-2030 (US$ Bn)
FIG. 74 Global Autoimmune Diseases Treatment Market, by Therapeutic & Monitoring Equipment, 2017-2030 (US$ Bn)
FIG. 75 North America Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 76 North America Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 77 U.S. Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 78 Canada Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 79 Europe Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 80 Germany Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 81 France Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 82 U.K. Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 83 Italy Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 84 Spain Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 85 Rest of Europe Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 86 Asia Pacific Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 87 China Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 88 Japan Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 89 India Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 90 South Korea Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 91 South-East Asia Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 92 Rest of Asia Pacific Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 93 Latin America Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 94 Brazil Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 95 Mexico Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 96 Rest of Latin America Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 97 Middle East & Africa Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 98 GCC Countries Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 99 South Africa Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)
FIG. 100 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Autoimmune Diseases Treatment Market
TABLE 2 Global Autoimmune Diseases Treatment Market: Market Drivers Impact Analysis
TABLE 3 Global Autoimmune Diseases Treatment Market: Market Restraints Impact Analysis
TABLE 4 Global Autoimmune Diseases Treatment Market, by Competitive Benchmarking, 2022
TABLE 5 Global Autoimmune Diseases Treatment Market, by Geographical Presence Analysis, 2022
TABLE 6 Global Autoimmune Diseases Treatment Market, by Key Strategies Analysis, 2022
TABLE 7 Global Autoimmune Diseases Treatment Market, by B Cell Inhibitors, By Region, 2017-2022 (US$ Bn)
TABLE 8 Global Autoimmune Diseases Treatment Market, by B Cell Inhibitors, By Region, 2023-2030 (US$ Bn)
TABLE 9 Global Autoimmune Diseases Treatment Market, by T Cell Inhibitors, By Region, 2017-2022 (US$ Bn)
TABLE 10 Global Autoimmune Diseases Treatment Market, by T Cell Inhibitors, By Region, 2023-2030 (US$ Bn)
TABLE 11 Global Autoimmune Diseases Treatment Market, by Tumor Necrosis Factor, By Region, 2017-2022 (US$ Bn)
TABLE 12 Global Autoimmune Diseases Treatment Market, by Tumor Necrosis Factor, By Region, 2023-2030 (US$ Bn)
TABLE 13 Global Autoimmune Diseases Treatment Market, by Graves Disease, By Region, 2017-2022 (US$ Bn)
TABLE 14 Global Autoimmune Diseases Treatment Market, by Graves Disease, By Region, 2023-2030 (US$ Bn)
TABLE 15 Global Autoimmune Diseases Treatment Market, by Rheumatoid Arthritis, By Region, 2017-2022 (US$ Bn)
TABLE 16 Global Autoimmune Diseases Treatment Market, by Rheumatoid Arthritis, By Region, 2023-2030 (US$ Bn)
TABLE 17 Global Autoimmune Diseases Treatment Market, by Hashimotos Thyroidtis, By Region, 2017-2022 (US$ Bn)
TABLE 18 Global Autoimmune Diseases Treatment Market, by Hashimotos Thyroidtis, By Region, 2023-2030 (US$ Bn)
TABLE 19 Global Autoimmune Diseases Treatment Market, by Vitiligo, By Region, 2017-2022 (US$ Bn)
TABLE 20 Global Autoimmune Diseases Treatment Market, by Vitiligo, By Region, 2023-2030 (US$ Bn)
TABLE 21 Global Autoimmune Diseases Treatment Market, by Hospitals & Clinics, By Region, 2017-2022 (US$ Bn)
TABLE 22 Global Autoimmune Diseases Treatment Market, by Hospitals & Clinics, By Region, 2023-2030 (US$ Bn)
TABLE 23 Global Autoimmune Diseases Treatment Market, by Diagnostic Centers, By Region, 2017-2022 (US$ Bn)
TABLE 24 Global Autoimmune Diseases Treatment Market, by Diagnostic Centers, By Region, 2023-2030 (US$ Bn)
TABLE 25 Global Autoimmune Diseases Treatment Market, by Crohn’s Disease, By Region, 2017-2022 (US$ Bn)
TABLE 26 Global Autoimmune Diseases Treatment Market, by Crohn’s Disease, By Region, 2023-2030 (US$ Bn)
TABLE 27 Global Autoimmune Diseases Treatment Market, by Hospitals & Clinics, By Region, 2017-2022 (US$ Bn)
TABLE 28 Global Autoimmune Diseases Treatment Market, by Hospitals & Clinics, By Region, 2023-2030 (US$ Bn)
TABLE 29 Global Autoimmune Diseases Treatment Market, by Diagnostic Centers, By Region, 2017-2022 (US$ Bn)
TABLE 30 Global Autoimmune Diseases Treatment Market, by Diagnostic Centers, By Region, 2023-2030 (US$ Bn)
TABLE 31 Global Autoimmune Diseases Treatment Market, by Crohn’s Disease, By Region, 2017-2022 (US$ Bn)
TABLE 32 Global Autoimmune Diseases Treatment Market, by Crohn’s Disease, By Region, 2023-2030 (US$ Bn)
TABLE 33 Global Autoimmune Diseases Treatment Market, by Hospitals & Clinics, By Region, 2017-2022 (US$ Bn)
TABLE 34 Global Autoimmune Diseases Treatment Market, by Hospitals & Clinics, By Region, 2023-2030 (US$ Bn)
TABLE 35 Global Autoimmune Diseases Treatment Market, by Diagnostic Centers, By Region, 2017-2022 (US$ Bn)
TABLE 36 Global Autoimmune Diseases Treatment Market, by Diagnostic Centers, By Region, 2023-2030 (US$ Bn)
TABLE 37 Global Autoimmune Diseases Treatment Market, by Crohn’s Disease, By Region, 2017-2022 (US$ Bn)
TABLE 38 Global Autoimmune Diseases Treatment Market, by Crohn’s Disease, By Region, 2023-2030 (US$ Bn)
TABLE 39 Global Autoimmune Diseases Treatment Market, by Hospitals & Clinics, By Region, 2017-2022 (US$ Bn)
TABLE 40 Global Autoimmune Diseases Treatment Market, by Hospitals & Clinics, By Region, 2023-2030 (US$ Bn)
TABLE 41 Global Autoimmune Diseases Treatment Market, by Diagnostic Centers, By Region, 2017-2022 (US$ Bn)
TABLE 42 Global Autoimmune Diseases Treatment Market, by Diagnostic Centers, By Region, 2023-2030 (US$ Bn)
TABLE 43 Global Autoimmune Diseases Treatment Market, by Crohn’s Disease, By Region, 2017-2022 (US$ Bn)
TABLE 44 Global Autoimmune Diseases Treatment Market, by Crohn’s Disease, By Region, 2023-2030 (US$ Bn)
TABLE 45 Global Autoimmune Diseases Treatment Market, by Hospitals & Clinics, By Region, 2017-2022 (US$ Bn)
TABLE 46 Global Autoimmune Diseases Treatment Market, by Hospitals & Clinics, By Region, 2023-2030 (US$ Bn)
TABLE 47 Global Autoimmune Diseases Treatment Market, by Diagnostic Centers, By Region, 2017-2022 (US$ Bn)
TABLE 48 Global Autoimmune Diseases Treatment Market, by Diagnostic Centers, By Region, 2023-2030 (US$ Bn)
TABLE 49 Global Autoimmune Diseases Treatment Market, by Crohn’s Disease, By Region, 2017-2022 (US$ Bn)
TABLE 50 Global Autoimmune Diseases Treatment Market, by Crohn’s Disease, By Region, 2023-2030 (US$ Bn)
TABLE 51 Global Autoimmune Diseases Treatment Market, by Rheumatoid Arthritis, By Region, 2017-2022 (US$ Bn)
TABLE 52 Global Autoimmune Diseases Treatment Market, by Rheumatoid Arthritis, By Region, 2023-2030 (US$ Bn)
TABLE 53 Global Autoimmune Diseases Treatment Market, by Inflammatory Bowel Disease, By Region, 2017-2022 (US$ Bn)
TABLE 54 Global Autoimmune Diseases Treatment Market, by Inflammatory Bowel Disease, By Region, 2023-2030 (US$ Bn)
TABLE 55 Global Autoimmune Diseases Treatment Market, by Multiple Sclerosis, By Region, 2017-2022 (US$ Bn)
TABLE 56 Global Autoimmune Diseases Treatment Market, by Multiple Sclerosis, By Region, 2023-2030 (US$ Bn)
TABLE 57 Global Autoimmune Diseases Treatment Market, by TNF Inhibitors, By Region, 2017-2022 (US$ Bn)
TABLE 58 Global Autoimmune Diseases Treatment Market, by TNF Inhibitors, By Region, 2023-2030 (US$ Bn)
TABLE 59 Global Autoimmune Diseases Treatment Market, by IL Blockers, By Region, 2017-2022 (US$ Bn)
TABLE 60 Global Autoimmune Diseases Treatment Market, by IL Blockers, By Region, 2023-2030 (US$ Bn)
TABLE 61 Global Autoimmune Diseases Treatment Market, by COX Inhibitors, By Region, 2017-2022 (US$ Bn)
TABLE 62 Global Autoimmune Diseases Treatment Market, by COX Inhibitors, By Region, 2023-2030 (US$ Bn)
TABLE 63 Global Autoimmune Diseases Treatment Market, by Phosphodiesterase Type 4 Inhibitors, By Region, 2017-2022 (US$ Bn)
TABLE 64 Global Autoimmune Diseases Treatment Market, by Phosphodiesterase Type 4 Inhibitors, By Region, 2023-2030 (US$ Bn)
TABLE 65 Global Autoimmune Diseases Treatment Market, by Others, By Region, 2017-2022 (US$ Bn)
TABLE 66 Global Autoimmune Diseases Treatment Market, by Others, By Region, 2023-2030 (US$ Bn)
TABLE 67 Global Autoimmune Diseases Treatment Market, by Autoantibody Tests, By Region, 2017-2022 (US$ Bn)
TABLE 68 Global Autoimmune Diseases Treatment Market, by Autoantibody Tests, By Region, 2023-2030 (US$ Bn)
TABLE 69 Global Autoimmune Diseases Treatment Market, by Antinuclear Antibody Tests, By Region, 2017-2022 (US$ Bn)
TABLE 70 Global Autoimmune Diseases Treatment Market, by Antinuclear Antibody Tests, By Region, 2023-2030 (US$ Bn)
TABLE 71 Global Autoimmune Diseases Treatment Market, by Urinalysis, By Region, 2017-2022 (US$ Bn)
TABLE 72 Global Autoimmune Diseases Treatment Market, by Urinalysis, By Region, 2023-2030 (US$ Bn)
TABLE 73 Global Autoimmune Diseases Treatment Market, by Drugs, By Region, 2017-2022 (US$ Bn)
TABLE 74 Global Autoimmune Diseases Treatment Market, by Drugs, By Region, 2023-2030 (US$ Bn)
TABLE 75 Global Autoimmune Diseases Treatment Market, by Physical Therapy, By Region, 2017-2022 (US$ Bn)
TABLE 76 Global Autoimmune Diseases Treatment Market, by Physical Therapy, By Region, 2023-2030 (US$ Bn)
TABLE 77 Global Autoimmune Diseases Treatment Market, by Prostate Cancer, By Region, 2017-2022 (US$ Bn)
TABLE 78 Global Autoimmune Diseases Treatment Market, by Prostate Cancer, By Region, 2023-2030 (US$ Bn)
TABLE 79 Global Autoimmune Diseases Treatment Market, by Colorectal Cancer, By Region, 2017-2022 (US$ Bn)
TABLE 80 Global Autoimmune Diseases Treatment Market, by Colorectal Cancer, By Region, 2023-2030 (US$ Bn)
TABLE 81 Global Autoimmune Diseases Treatment Market, by Melanoma, By Region, 2017-2022 (US$ Bn)
TABLE 82 Global Autoimmune Diseases Treatment Market, by Melanoma, By Region, 2023-2030 (US$ Bn)
TABLE 83 Global Autoimmune Diseases Treatment Market, by Other cancers, By Region, 2017-2022 (US$ Bn)
TABLE 84 Global Autoimmune Diseases Treatment Market, by Other cancers, By Region, 2023-2030 (US$ Bn)
TABLE 85 Global Autoimmune Diseases Treatment Market, by Non-Oncology Disorders, By Region, 2017-2022 (US$ Bn)
TABLE 86 Global Autoimmune Diseases Treatment Market, by Non-Oncology Disorders, By Region, 2023-2030 (US$ Bn)
TABLE 87 Global Autoimmune Diseases Treatment Market, by Diagnostic Equipment, By Region, 2017-2022 (US$ Bn)
TABLE 88 Global Autoimmune Diseases Treatment Market, by Diagnostic Equipment, By Region, 2023-2030 (US$ Bn)
TABLE 89 Global Autoimmune Diseases Treatment Market, by Drugs, By Region, 2017-2022 (US$ Bn)
TABLE 90 Global Autoimmune Diseases Treatment Market, by Drugs, By Region, 2023-2030 (US$ Bn)
TABLE 91 Global Autoimmune Diseases Treatment Market, by Therapeutic & Monitoring Equipment, By Region, 2017-2022 (US$ Bn)
TABLE 92 Global Autoimmune Diseases Treatment Market, by Therapeutic & Monitoring Equipment, By Region, 2023-2030 (US$ Bn)
TABLE 93 Global Autoimmune Diseases Treatment Market, by Diagnosis and Screening, By Region, 2017-2022 (US$ Bn)
TABLE 94 Global Autoimmune Diseases Treatment Market, by Diagnosis and Screening, By Region, 2023-2030 (US$ Bn)
TABLE 95 Global Autoimmune Diseases Treatment Market, by Region, 2017-2022 (US$ Bn)
TABLE 96 Global Autoimmune Diseases Treatment Market, by Region, 2023-2030 (US$ Bn)
TABLE 97 North America Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 98 North America Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 99 North America Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 100 North America Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 101 North America Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 102 North America Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 103 North America Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 104 North America Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 105 North America Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 106 North America Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 107 North America Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 108 North America Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 109 North America Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 110 North America Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 111 North America Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 112 North America Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 113 North America Autoimmune Diseases Treatment Market, by Country, 2017-2022 (US$ Bn)
TABLE 114 North America Autoimmune Diseases Treatment Market, by Country, 2023-2030 (US$ Bn)
TABLE 115 United States Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 116 United States Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 117 United States Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 118 United States Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 119 United States Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 120 United States Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 121 United States Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 122 United States Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 123 United States Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 124 United States Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 125 United States Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 126 United States Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 127 United States Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 128 United States Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 129 United States Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 130 United States Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 131 Canada Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 132 Canada Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 133 Canada Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 134 Canada Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 135 Canada Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 136 Canada Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 137 Canada Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 138 Canada Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 139 Canada Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 140 Canada Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 141 Canada Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 142 Canada Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 143 Canada Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 144 Canada Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 145 Canada Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 146 Canada Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 147
TABLE 148 Mexico Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 149 Mexico Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 150 Mexico Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 151 Mexico Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 152 Mexico Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 153 Mexico Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 154 Mexico Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 155 Mexico Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 156 Mexico Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 157 Mexico Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 158 Mexico Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 159 Mexico Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 160 Mexico Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 161 Mexico Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 162 Mexico Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 163 Mexico Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 164 Europe Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 165 Europe Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 166 Europe Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 167 Europe Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 168 Europe Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 169 Europe Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 170 Europe Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 171 Europe Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 172 Europe Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 173 Europe Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 174 Europe Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 175 Europe Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 176 Europe Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 177 Europe Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 178 Europe Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 179 Europe Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 180 Europe Autoimmune Diseases Treatment Market, by Country, 2017-2022 (US$ Bn)
TABLE 181 Europe Autoimmune Diseases Treatment Market, by Country, 2023-2030 (US$ Bn)
TABLE 182 Germany Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 183 Germany Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 184 Germany Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 185 Germany Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 186 Germany Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 187 Germany Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 188 Germany Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 189 Germany Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 190 Germany Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 191 Germany Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 192 Germany Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 193 Germany Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 194 Germany Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 195 Germany Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 196 Germany Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 197 Germany Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 198 France Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 199 France Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 200 France Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 201 France Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 202 France Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 203 France Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 204 France Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 205 France Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 206 France Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 207 France Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 208 France Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 209 France Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 210 France Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 211 France Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 212 France Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 213 France Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 214 United Kingdom Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 215 United Kingdom Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 216 United Kingdom Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 217 United Kingdom Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 218 United Kingdom Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 219 United Kingdom Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 220 United Kingdom Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 221 United Kingdom Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 222 United Kingdom Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 223 United Kingdom Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 224 United Kingdom Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 225 United Kingdom Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 226 United Kingdom Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 227 United Kingdom Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 228 United Kingdom Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 229 United Kingdom Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 230 Italy Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 231 Italy Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 232 Italy Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 233 Italy Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 234 Italy Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 235 Italy Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 236 Italy Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 237 Italy Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 238 Italy Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 239 Italy Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 240 Italy Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 241 Italy Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 242 Italy Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 243 Italy Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 244 Italy Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 245 Italy Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 246 Spain Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 247 Spain Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 248 Spain Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 249 Spain Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 250 Spain Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 251 Spain Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 252 Spain Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 253 Spain Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 254 Spain Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 255 Spain Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 256 Spain Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 257 Spain Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 258 Spain Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 259 Spain Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 260 Spain Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 261 Spain Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 262 Rest of Europe Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 263 Rest of Europe Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 264 Rest of Europe Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 265 Rest of Europe Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 266 Rest of Europe Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 267 Rest of Europe Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 268 Rest of Europe Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 269 Rest of Europe Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 270 Rest of Europe Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 271 Rest of Europe Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 272 Rest of Europe Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 273 Rest of Europe Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 274 Rest of Europe Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 275 Rest of Europe Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 276 Rest of Europe Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 277 Rest of Europe Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 278 Asia Pacific Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 279 Asia Pacific Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 280 Asia Pacific Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 281 Asia Pacific Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 282 Asia Pacific Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 283 Asia Pacific Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 284 Asia Pacific Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 285 Asia Pacific Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 286 Asia Pacific Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 287 Asia Pacific Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 288 Asia Pacific Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 289 Asia Pacific Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 290 Asia Pacific Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 291 Asia Pacific Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 292 Asia Pacific Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 293 Asia Pacific Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 294 China Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 295 China Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 296 China Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 297 China Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 298 China Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 299 China Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 300 China Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 301 China Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 302 China Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 303 China Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 304 China Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 305 China Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 306 China Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 307 China Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 308 China Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 309 China Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 310 Japan Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 311 Japan Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 312 Japan Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 313 Japan Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 314 Japan Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 315 Japan Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 316 Japan Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 317 Japan Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 318 Japan Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 319 Japan Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 320 Japan Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 321 Japan Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 322 Japan Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 323 Japan Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 324 Japan Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 325 Japan Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 326 India Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 327 India Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 328 India Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 329 India Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 330 India Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 331 India Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 332 India Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 333 India Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 334 India Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 335 India Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 336 India Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 337 India Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 338 India Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 339 India Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 340 India Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 341 India Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 342 South Korea Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 343 South Korea Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 344 South Korea Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 345 South Korea Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 346 South Korea Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 347 South Korea Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 348 South Korea Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 349 South Korea Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 350 South Korea Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 351 South Korea Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 352 South Korea Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 353 South Korea Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 354 South Korea Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 355 South Korea Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 356 South Korea Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 357 South Korea Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 358 South-East Asia Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 359 South-East Asia Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 360 South-East Asia Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 361 South-East Asia Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 362 South-East Asia Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 363 South-East Asia Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 364 South-East Asia Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 365 South-East Asia Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 366 South-East Asia Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 367 South-East Asia Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 368 South-East Asia Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 369 South-East Asia Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 370 South-East Asia Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 371 South-East Asia Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 372 South-East Asia Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 373 South-East Asia Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 374 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 375 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 376 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 377 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 378 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 379 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 380 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 381 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 382 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 383 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 384 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 385 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 386 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 387 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 388 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 389 Rest of Asia Pacific Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 390 Latin America Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 391 Latin America Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 392 Latin America Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 393 Latin America Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 394 Latin America Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 395 Latin America Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 396 Latin America Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 397 Latin America Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 398 Latin America Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 399 Latin America Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 400 Latin America Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 401 Latin America Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 402 Latin America Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 403 Latin America Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 404 Latin America Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 405 Latin America Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 406 Brazil Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 407 Brazil Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 408 Brazil Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 409 Brazil Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 410 Brazil Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 411 Brazil Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 412 Brazil Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 413 Brazil Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 414 Brazil Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 415 Brazil Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 416 Brazil Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 417 Brazil Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 418 Brazil Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 419 Brazil Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 420 Brazil Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 421 Brazil Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 422 Argentina Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 423 Argentina Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 424 Argentina Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 425 Argentina Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 426 Argentina Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 427 Argentina Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 428 Argentina Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 429 Argentina Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 430 Argentina Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 431 Argentina Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 432 Argentina Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 433 Argentina Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 434 Argentina Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 435 Argentina Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 436 Argentina Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 437 Argentina Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 438 Rest of Latin America Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 439 Rest of Latin America Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 440 Rest of Latin America Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 441 Rest of Latin America Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 442 Rest of Latin America Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 443 Rest of Latin America Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 444 Rest of Latin America Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 445 Rest of Latin America Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 446 Rest of Latin America Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 447 Rest of Latin America Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 448 Rest of Latin America Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 449 Rest of Latin America Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 450 Rest of Latin America Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 451 Rest of Latin America Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 452 Rest of Latin America Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 453 Rest of Latin America Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 454 Middle East and Africa Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 455 Middle East and Africa Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 456 Middle East and Africa Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 457 Middle East and Africa Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 458 Middle East and Africa Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 459 Middle East and Africa Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 460 Middle East and Africa Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 461 Middle East and Africa Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 462 Middle East and Africa Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 463 Middle East and Africa Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 464 Middle East and Africa Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 465 Middle East and Africa Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 466 Middle East and Africa Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 467 Middle East and Africa Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 468 Middle East and Africa Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 469 Middle East and Africa Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 470 GCC Countries Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 471 GCC Countries Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 472 GCC Countries Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 473 GCC Countries Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 474 GCC Countries Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 475 GCC Countries Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 476 GCC Countries Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 477 GCC Countries Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 478 GCC Countries Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 479 GCC Countries Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 480 GCC Countries Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 481 GCC Countries Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 482 GCC Countries Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 483 GCC Countries Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 484 GCC Countries Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 485 GCC Countries Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 486 South Africa Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 487 South Africa Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 488 South Africa Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 489 South Africa Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 490 South Africa Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 491 South Africa Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 492 South Africa Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 493 South Africa Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 494 South Africa Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 495 South Africa Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 496 South Africa Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 497 South Africa Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 498 South Africa Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 499 South Africa Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 500 South Africa Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 501 South Africa Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)
TABLE 502 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Product Type, 2017-2022 (US$ Bn)
TABLE 503 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Product Type, 2023-2030 (US$ Bn)
TABLE 504 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Application, 2017-2022 (US$ Bn)
TABLE 505 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Application, 2023-2030 (US$ Bn)
TABLE 506 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Distribution Channel, 2017-2022 (US$ Bn)
TABLE 507 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Distribution Channel, 2023-2030 (US$ Bn)
TABLE 508 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Disease, 2017-2022 (US$ Bn)
TABLE 509 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Disease, 2023-2030 (US$ Bn)
TABLE 510 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Mechanism of Action, 2017-2022 (US$ Bn)
TABLE 511 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Mechanism of Action, 2023-2030 (US$ Bn)
TABLE 512 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Diagnostic, 2017-2022 (US$ Bn)
TABLE 513 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Diagnostic, 2023-2030 (US$ Bn)
TABLE 514 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Treatment, 2017-2022 (US$ Bn)
TABLE 515 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Treatment, 2023-2030 (US$ Bn)
TABLE 516 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Product, 2017-2022 (US$ Bn)
TABLE 517 Rest of Middle East and Africa Autoimmune Diseases Treatment Market, by Product, 2023-2030 (US$ Bn)

Frequently Asked Questions:

How does COVID-19 Impact the global Autoimmune Diseases Treatment market?

COVID-19 has considerably impacted the market due to the growing number of cases and the government’s lockdown implications, which slowed the R&D for other treatments and drugs.

Which is the leading region of the market for Autoimmune Diseases Treatment?

North America accounted for the largest market share of the global Autoimmune Diseases Treatment market.

What are the key drivers for the growth of the Autoimmune Diseases Treatment market?

Growing R&D activities, rising prevalence of autoimmune diseases, and increasing investments to drive the Autoimmune Diseases Treatment market.

Which is the major Autoimmune Diseases Treatment market segment by Product Type?

The B Cell Inhibitors segment had a major share of the global market in 2022.

Who are the major players in this market?

Genentech Inc., Bayer AG, Merck & Co., Amgen Inc., Johnson & Johnson Limited are some of the major players in the global market.

United States Human Papillomavirus Vaccines Market

Published:
Report ID: 36384

White Canes Market

Published:
Report ID: 36378

Cancer Profiling Market

Published:
Report ID: 36289

Flowable Hemostats Market

Published:
Report ID: 36279

Fibrin Sealants Market

Published:
Report ID: 36276

Prostate Cancer Market

Published:
Report ID: 36273

ECG Telemetry Devices Market

Published:
Report ID: 36237

Blotting Systems Market

Published:
Report ID: 36233

India Dental Consumables Market

Published:
Report ID: 36214

Biotechnology and Pharmaceutical Services Outsourcing Market

Published:
Report ID: 36191

India Bariatric Surgery Devices Market

Published:
Report ID: 36164

Veterinary Imaging Systems Market

Published:
Report ID: 36104

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN